Angel® Catheter - A solution to pulmonary embolism prophylaxis in the critically ill patient

Luis F. Angel

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Pulmonary embolism (PE) is a serious complication among critically ill patients. Despite the recommended and effective use of prophylactic anticoagulation, new options are required, particularly for critically ill patients with absolute or temporary contraindications to the use of anticoagulation. The Angel® Catheter (BiO2 Medical, Inc. San Antonio, Texas) is intended for these critically ill patients, allowing early PE prophylaxis without additional bleeding risk. The device is inserted at the bedside, provides both central venous access and inferior vena cava filtration, and can be successfully removed in all instances. Clinical experience and ongoing research will help define the role of the Angel Catheter in PE prophylaxis for critically ill patients.

Original languageEnglish (US)
Pages (from-to)8-9
Number of pages2
JournalJournal of the Intensive Care Society
Volume15
Issue number1
DOIs
StatePublished - Jan 2014

Keywords

  • Angel Catheter
  • Inferior vena cava filters
  • Intensive care unit
  • Pulmonary embolism
  • Thrombophrophylaxis

ASJC Scopus subject areas

  • Critical Care
  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Angel® Catheter - A solution to pulmonary embolism prophylaxis in the critically ill patient'. Together they form a unique fingerprint.

Cite this